EDITORIAL-DETAILS (JPDM)
![](http://www.jscholarpublishers.com/JSAP2/admin/up_images/261editor_image.jpg)
Yi Zhun ZHU
Professor of Pharmacology
Dean, School of Pharmacy Fudan University
China
Biography
Dr. Yi Zhun Zhu got his M.D./Ph.D. at Faculty of Medicine, University of Heidelberg, Germany in 1995. He joined as a faculty member of the Department of Pharmacology, National University of Singapore (NUS) in 1998 after postdoc training at Kiel University and industrial experience at Hoechst Marion Roussel (now Sanofil). Dr. Zhu is currently a Professor of Pharmacology (also as adj-professor at Pharmacology, NUS), Dean of School of Pharmacy and Director, Institute of Drug R&D, Fudan University. Dr. Zhu published more than 100 peer-reviewed papers with more than 2300 citations and edited 2 books for his work. He is an associate editor J Alzheimer Diseases, Life Sciences and editorial board member of Biosci. Reports, J of Pharmacology and Drug Metabolism. Dr. Zhu is also editor-in-chief for the national text book of Pharmacology (7th edition, People’s Medical Publishing House), Dr. Zhu was awarded Lee Kuan Yew Research Fellowship in 1998 from Singapore, ‘distinguished Young Scientist Grant from Natural Science Foundation of China (NSFC) in 2008, Chief Scientist of National Key Research Program (973) and Chief-PI for the National Platform of Drug Discovery in 2009. Dr. Zhu further received National Award for Innovative Research Work of the Returnees in 2009 from State Council and Magnolia Award from Shanghai Government in 2010. Dr. Zhu was awarded 2011 Cheung Kong Professorship by the Ministry of Education, China. His research focuses on molecular pharmacology/drug mechanisms especially for heart and brain. Two novel compounds as drug candidates have been completed pre-clinical trials and are moving to clinical trails now.
Research Interest
Molecular pharmacology/drug mechanisms especially for heart and brain. Two novel compounds as drug candidates have been completed pre-clinical trials and are moving to clinical trails now.